Jeff is the experienced CEO of Sequoia Biotech, a promising clinical-stage company. An industry veteran who has been through multiple company financings, he has learned how to create a competitive dynamic including the time and effort that goes into a well-run deal cycle. Read More
A Tale of Two Deals
MotionHall provides the unexpected market insights dealmakers need to play their cards right.